Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer
Clinical trial NCT02943317 · TERMINATED
Trial details
- NCT number
- NCT02943317
- Sponsor
- Verastem, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-08-28
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.